ScholarIQanswers from OpenAlex
Azienda Ospedaliera Ospedale San Carlo Borromeo
InstitutionResearch output, impact & collaborations
Azienda Ospedaliera Ospedale San Carlo Borromeo is a institution indexed in ScholarIQ from OpenAlex.
What is known about Azienda Ospedaliera Ospedale San Carlo Borromeo?
ScholarIQrecord summary
Azienda Ospedaliera Ospedale San Carlo Borromeo is a research organisation in Milan, IT. OpenAlex records 340 works and 18,936 citations for it. 58 researchers list it as their most recent affiliation.
How many works does Azienda Ospedaliera Ospedale San Carlo Borromeo have?
ScholarIQindexed works
Azienda Ospedaliera Ospedale San Carlo Borromeo has 340 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Azienda Ospedaliera Ospedale San Carlo Borromeo have?
ScholarIQcitation count
Azienda Ospedaliera Ospedale San Carlo Borromeo has 18,936 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Azienda Ospedaliera Ospedale San Carlo Borromeo?
ScholarIQresearcher count
Azienda Ospedaliera Ospedale San Carlo Borromeo has 58 researchers in the ScholarIQ index.
What is the average h-index at Azienda Ospedaliera Ospedale San Carlo Borromeo?
ScholarIQavg h-index
Azienda Ospedaliera Ospedale San Carlo Borromeo has an average h-index of 22 in OpenAlex.
What is the ROR of Azienda Ospedaliera Ospedale San Carlo Borromeo?
ScholarIQror
The ROR for Azienda Ospedaliera Ospedale San Carlo Borromeo is on the source record.
What is the OpenAlex record for Azienda Ospedaliera Ospedale San Carlo Borromeo?
ScholarIQopenalex
The OpenAlex for Azienda Ospedaliera Ospedale San Carlo Borromeo is on the source record.
Who are the most-cited researchers behind Azienda Ospedaliera Ospedale San Carlo Borromeo?
ScholarIQtop researchers by citations
What are the most-cited papers on Azienda Ospedaliera Ospedale San Carlo Borromeo?
ScholarIQmost cited works
Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
G. Frasci, Vito Lorusso, Nicola Panza, Pasquale Comella, G.P. Nicolella, Andrea Bianco, Giuseppe De Cataldis, Annunziato Iannelli, Domenico Bilancia, M Belli, B. Massidda, Francovito Piantedosi, Giuseppe Comella, Mario De Lena
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
Khalid El Bairi, Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh Ardalan, Luciana Botinelly Mendonça Fujimoto, Luz F. Sua, Shiwei Liu, Huang‐Chun Lien, Pawan Kirtani, Marcelo Balancin, H. El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I‐Chun Chen, Verónica Bautista, José Fernando do Prado Moura, Bernardo L. Rapoport, Carlos Castaneda, Eunice Spengler, Gabriela Acosta-Haab, Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard‐Gallo, An Coosemans, Edith Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M.S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, W. Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernán Garcı́a Rivello, Hugo M. Horlings, Saïd Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group, Khalid El Bairi, Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Botinelly Mendonça Fujimoto, Luz F. Sua, Shiwei Liu, Huang‐Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I‐Chun Chen, Veronica Bautista
Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology Group
Pasquale Comella, G. Frasci, Nicola Panza, Luigi Manzione, Giuseppe De Cataldis, R Cioffi, Luigi Maiorino, E Micillo, Vito Lorusso, Gaetano Di Rienzo, Gianfranco Filippelli, Alfredo Lamberti, Michèle Natale, Domenico Bilancia, G.P. Nicolella, A. Di Nota, Giuseppe Comella
Lapatinib in breast cancer
Domenico Bilancia, Gerardo Rosati, Angelo Dinota, Domenico Germano, Rosangela Romano, Luigi Manzione
Cisplatin, Gemcitabine, and Vinorelbine Combination Therapy in Advanced Non–Small-Cell Lung Cancer: A Phase II Randomized Study of the Southern Italy Cooperative Oncology Group
Pasquale Comella, G. Frasci, Nicola Panza, Luigi Manzione, Vito Lorusso, Gaetano Di Rienzo, R Cioffi, Giuseppe De Cataldis, Luigi Maiorino, Domenico Bilancia, G.P. Nicolella, Michèle Natale, Franco Carpagnano, Carmen Pacilio, Mario De Lena, Andrea Bianco, Giuseppe Comella
How much of the research on Azienda Ospedaliera Ospedale San Carlo Borromeo is open access?
ScholarIQopen access share
45%OPEN ACCESS